Q-omics provides the consensus-scored RPSAP62 profile across patient tissues and cancer cell-line models. RPSAP62 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, RPSAP62 is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, RPSAP62 RNA expression shows 4,827 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, THCA, and STAD as cancer lineages where RPSAP62 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPSAP62 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPSAP62 survival associations across molecular data types. RPSAP62 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPSAP62 RNA expression–survival associations across cancer types. High RPSAP62 expression shows unfavorable associations in KIRC, UCEC, BRCA, KICH and ESCA, but favorable associations in SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for RPSAP62 RNA expression.
This table summarizes RPSAP62 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPSAP62. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPSAP62 shows lower tumor expression in THCA. The THCA box plot shows higher RPSAP62 RNA expression in normal versus tumor tissue (log2 FC = −0.012, t-test p = .035).
This table shows molecular features associated with RPSAP62 in patient tissues and cancer cell lines. In patient samples, RPSAP62 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
